Oncologie-richtlijnen

79 actuele Oncologie-richtlijnen van nationale agentschappen, Europese verenigingen en HTA-instanties, verdeeld over 13 bronnengroepen. eUvidence verankert Oncologie-antwoorden in deze richtlijnen; elke vermelding linkt naar de eigen pagina van de uitgevende instantie.

Europese verenigingen· 26

• Early and locally advanced non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

  ESMO · European Society for Medical Oncology · 2025

• Cutaneous melanoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

  ESMO · European Society for Medical Oncology · 2025

• ESMO Clinical Practice Guideline Express Update on the management of metastatic pancreatic cancer

  ESMO · European Society for Medical Oncology · 2025

• Hepatocellular carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

  ESMO · European Society for Medical Oncology · 2025

• Lymphomas: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

  ESMO · European Society for Medical Oncology · 2025

• Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

  ESMO · European Society for Medical Oncology · 2024

• Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

  ESMO · European Society for Medical Oncology · 2024

• ESMO Clinical Practice Guideline interim update on new targeted therapies in the first line and at relapse of chronic lymphocytic leukaemia

  ESMO · European Society for Medical Oncology · 2024

• Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

  ESMO · European Society for Medical Oncology · 2023

• Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

  ESMO · European Society for Medical Oncology · 2023

• Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

  ESMO · European Society for Medical Oncology · 2023

• Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

  ESMO · European Society for Medical Oncology · 2023

• Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

  ESMO · European Society for Medical Oncology · 2023

• Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

  ESMO · European Society for Medical Oncology · 2022

• Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

  ESMO · European Society for Medical Oncology · 2022

• Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

  ESMO · European Society for Medical Oncology · 2022

• Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

  ESMO · European Society for Medical Oncology · 2022

• Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

  ESMO · European Society for Medical Oncology · 2022

• Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

  ESMO · European Society for Medical Oncology · 2021

• ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer

  ESMO · European Society for Medical Oncology · 2021

• Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up

  EHA · European Hematology Association · 2021

• EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood

  EANO · European Association of Neuro-Oncology · 2021

• Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

  ESMO · European Society for Medical Oncology · 2020

• Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

  ESMO · European Society for Medical Oncology · 2020

• Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up

  ESMO · European Society for Medical Oncology · 2020

• Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines

  ESMO · European Society for Medical Oncology · 2018

België· 3

• Guideline on the management of rectal cancer

  KCE · Belgian Health Care Knowledge Centre · 2016

• Colon cancer: diagnosis, treatment and follow-up

  KCE · Belgian Health Care Knowledge Centre · 2014

• Informed choice on breast cancer screening: messages to support informed decision

  KCE · Belgian Health Care Knowledge Centre · 2014 · recommendation

Denemarken· 4

• Oncological Treatment of Inoperable Metastatic Melanoma

  DMCG · Dansk Melanom Gruppe (Danske Multidisciplinaere Cancer Grupper) · 2025

• Curative Radiotherapy for Prostate Cancer

  DMCG · Dansk Prostata Cancer Gruppe (Danske Multidisciplinaere Cancer Grupper) · 2025

• Breast Cancer: Follow-up

  DMCG · Danish Breast Cancer Group (Danske Multidisciplinaere Cancer Grupper) · 2025

• Treatment of Acute Myeloid Leukaemia (AML)

  DMCG · Akut Leukaemi Gruppen (Danske Multidisciplinaere Cancer Grupper) · 2024

Frankrijk· 9

• Pilot Programme for Organized Lung Cancer Screening — Summary of Retained Proposals

  INCa · Institut National du Cancer · 2024 · recommendation

• Cutaneous Melanomas — From Diagnosis to Follow-up (General Practitioner Practice Tool)

  INCa · Institut National du Cancer · 2024 · good practice guide

• Targeted Biopsies in the Diagnosis of Prostate Cancer

  HAS · Haute Autorité de Santé · 2023 · recommendation

• Patients with Cutaneous or Mucosal Melanoma: Indications for Molecular Testing for Prescribing Precision Treatments

  INCa · Institut National du Cancer · 2023 · recommendation

• National Organizational Reference Framework: Supportive Oncology Care for Adult Cancer Patients

  INCa · Institut National du Cancer · 2021 · good practice guide

• Colorectal Cancer: Screening and Prevention Modalities in Subjects at High and Very High Risk

  HAS · Haute Autorité de Santé · 2017 · recommendation

• Women Carrying a BRCA1 or BRCA2 Mutation: Early Detection of Breast and Adnexal Cancer and Risk-Reduction Strategies (Synthesis)

  INCa · Institut National du Cancer · 2017 · recommendation

• Breast Cancer Screening According to Risk Factor

  HAS · Haute Autorité de Santé · 2014 · recommendation

• Colorectal Cancer Screening and Prevention (Health Examination Centres Reference Document)

  HAS · Haute Autorité de Santé · 2013 · good practice guide

Duitsland· 10

• Colorectal Cancer

  LL-Onko · Leitlinienprogramm Onkologie · 2026

• Supportive Therapy in Oncology Patients

  LL-Onko · Leitlinienprogramm Onkologie · 2026

• Diagnosis, Therapy and Follow-up of Malignant Ovarian Tumors

  LL-Onko · Leitlinienprogramm Onkologie · 2026

• Early Detection, Diagnosis, Therapy and Follow-up of Breast Cancer

  LL-Onko · Leitlinienprogramm Onkologie · 2025

• Prostate Cancer

  LL-Onko · Leitlinienprogramm Onkologie · 2025

• Prevention, Diagnosis, Therapy and Follow-up of Lung Cancer

  LL-Onko · Leitlinienprogramm Onkologie · 2025

• Diagnosis and Therapy of Adenocarcinomas of the Stomach and Esophagogastric Junction

  LL-Onko · Leitlinienprogramm Onkologie · 2025

• Exocrine Pancreatic Cancer

  LL-Onko · Leitlinienprogramm Onkologie · 2024

• Diagnosis, Therapy and Follow-up of Melanoma

  LL-Onko · Leitlinienprogramm Onkologie · 2020

• Palliative Care for Patients with Incurable Cancer

  LL-Onko · Leitlinienprogramm Onkologie · 2020

Ierland· 2

• Diagnosis, Staging and Treatment of Patients with Lung Cancer: National Clinical Guideline No. 16

  NCCP · National Cancer Control Programme, Health Service Executive · 2017

• Diagnosis, Staging and Treatment of Patients with Breast Cancer: National Clinical Guideline No. 7

  NCCP · National Cancer Control Programme, Health Service Executive · 2015

Italië· 1

• Melanoma

  AIOM · Associazione Italiana di Oncologia Medica · 2023

Nederland· 8

• Colorectal Cancer

  FMS · Federatie Medisch Specialisten · 2026

• Melanoma

  FMS · Federatie Medisch Specialisten · 2026

• Breast Cancer

  FMS · Federatie Medisch Specialisten · 2025

• Non-Small Cell Lung Cancer

  FMS · Federatie Medisch Specialisten · 2025

• Gastric Cancer

  FMS · Federatie Medisch Specialisten · 2025

• Esophageal Cancer

  FMS · Federatie Medisch Specialisten · 2024

• Pancreatic Cancer

  FMS · Federatie Medisch Specialisten · 2019

• Prostate Cancer

  FMS · Federatie Medisch Specialisten · 2016

Noorwegen· 3

• National Action Programme with Guidelines for Colorectal Cancer

  Helsedir · Norwegian Directorate of Health · 2026

• National Action Programme with Guidelines for Breast Cancer

  Helsedir · Norwegian Directorate of Health · 2026

• National Action Programme with Guidelines for Prostate Cancer

  Helsedir · Norwegian Directorate of Health · 2025

Polen· 2

• Clinical Practice Guideline Recommendation No. 178/2025 on Lung Cancer Screening with Low-Dose Computed Tomography

  AOTMiT · Agencja Oceny Technologii Medycznych i Taryfikacji · 2025 · recommendation

• Diagnostic and Therapeutic Guidelines for Breast Cancer

  PTOK · Polskie Towarzystwo Onkologii Klinicznej · 2020

Portugal· 1

• Breast Carcinoma: Adjuvant Treatment

  DGS · Direcao-Geral da Saude · 2011

Zweden· 2

• National Care Programme for Breast Cancer

  RCC · Regional Cancer Centres in Collaboration · 2025

• National Care Programme for Prostate Cancer - Short Version for General Practitioners

  RCC · Regional Cancer Centres in Collaboration · 2025

Verenigd Koninkrijk· 8

• Suspected cancer: recognition and referral

  NICE · National Institute for Health and Care Excellence · 2025

• Early and locally advanced breast cancer: diagnosis and management

  NICE · National Institute for Health and Care Excellence · 2025

• Advanced breast cancer: diagnosis and treatment

  NICE · National Institute for Health and Care Excellence · 2025

• Lung cancer: diagnosis and management

  NICE · National Institute for Health and Care Excellence · 2024

• Melanoma: assessment and management

  NICE · National Institute for Health and Care Excellence · 2022

• Colorectal cancer

  NICE · National Institute for Health and Care Excellence · 2021

• Prostate cancer: diagnosis and management

  NICE · National Institute for Health and Care Excellence · 2021

• Pancreatic cancer in adults: diagnosis and management

  NICE · National Institute for Health and Care Excellence · 2018